Trial
NCT00515281
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Prematurity
Intervention
inhaled nitric oxide
Why stopped
The pace of patient enrolledment forced recruitment to stop after 273 patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-17